Cvijic Christine Mikail

CIK 00015436634 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001543663

Recent Transactions

36 trades

Sale
Neurogene Inc.$NGNE
Common Stock
2026-07-07$36.13/sh−4,200→ 84,040 total
Sale
Neurogene Inc.$NGNE
Common Stock
2026-07-06$36.02/sh−600→ 88,240 total
Sale
Neurogene Inc.$NGNE
Common Stock
2026-07-02$34.58/sh−2,531→ 90,370 total
Sale
Neurogene Inc.$NGNE
Common Stock
2026-07-02$35.23/sh−1,530→ 88,840 total
Sale
Neurogene Inc.$NGNE
Common Stock
2026-07-01$34.06/sh−739→ 92,901 total
Sale
Neurogene Inc.$NGNE
Common Stock
2026-05-06$30.07/sh−4,800→ 98,440 total
Sale
Neurogene Inc.$NGNE
Common Stock
2026-05-06$32.44/sh−4,800→ 93,640 total
Sale
Neurogene Inc.$NGNE
Common Stock
2026-03-26$21.62/sh−2,558→ 103,240 total
Sale
Neurogene Inc.$NGNE
Common Stock
2026-03-13$22.02/sh−263→ 105,798 total
Sale
Neurogene Inc.$NGNE
Common Stock
2026-03-13$20.42/sh−2,387→ 107,456 total
Sale
Neurogene Inc.$NGNE
Common Stock
2026-03-13$21.25/sh−1,395→ 106,061 total
Sale
Neurogene Inc.$NGNE
Common Stock
2026-02-27$25.11/sh−4,800→ 109,843 total
Award
Neurogene Inc.$NGNE
Stock Option (Right to Buy)
2026-02-20+131,900→ 131,900 total
Award
Neurogene Inc.$NGNE
Common Stock
2026-02-20+22,000→ 114,643 total
Award
Neurogene Inc.$NGNE
Common Stock
2025-03-26+20,300→ 92,643 total
Award
Neurogene Inc.$NGNE
Employee Stock Option (Right to buy)
2025-03-26+122,000→ 122,000 total
Sale
Neurogene Inc.$NGNE
Common Stock
2025-03-13$16.94/sh−4,501→ 72,343 total
Purchase
Neurogene Inc.$NGNE
Common Stock
2024-11-22$20.48/sh+24,000→ 76,844 total
Award
Neurogene Inc.$NGNE
Employee Stock Option (Right to buy)
2024-03-13+53,900→ 53,900 total
Award
Neurogene Inc.$NGNE
Common Stock
2024-03-13+31,903→ 52,844 total
Award
Sio Gene Therapies Inc.
Employee Stock Option (Right to Buy)
2016-04-29+50,000→ 50,000 total
Disposition to Issuer
NPS PHARMACEUTICALS INC
Restricted Stock Units
2015-02-21−29,085→ 0 total
Disposition to Issuer
NPS PHARMACEUTICALS INC
Stock Options (right to buy)
2015-02-21−79,453→ 0 total
Disposition to Issuer
NPS PHARMACEUTICALS INC
Restricted Stock Units
2015-02-21−10,905→ 0 total
Award
NPS PHARMACEUTICALS INC
Restricted Stock Units
2015-02-12+10,905→ 10,905 total
Award
DENDREON CORP
Common Stock
2014-02-10+17,956→ 357,632 total
Tax Payment
DENDREON CORP
Common Stock
2014-02-10$2.81/sh−6,167→ 351,465 total
Award
DENDREON CORP
Common Stock
2014-01-03+200,000→ 349,132 total
Tax Payment
DENDREON CORP
Common Stock
2014-01-03$3.08/sh−9,456→ 339,676 total
Tax Payment
DENDREON CORP
Common Stock
2013-12-08$3.01/sh−1,380→ 149,132 total
Tax Payment
DENDREON CORP
Common Stock
2013-09-08$2.88/sh−1,380→ 150,512 total
Tax Payment
DENDREON CORP
Common Stock
2013-06-08$3.90/sh−1,380→ 151,892 total
Tax Payment
DENDREON CORP
Common Stock
2013-03-08$5.91/sh−5,520→ 153,272 total
Award
DENDREON CORP
Common Stock
2013-01-03+94,502→ 158,792 total
Award
DENDREON CORP
Common Stock
2012-03-08+64,290→ 64,290 total
Award
DENDREON CORP
Non-Qualified Stock Option (right to buy)
2012-03-08$10.12/sh+128,580→ 128,580 total

Companies

Recent Filings

Address

C/O NEUROGENE INC. 535 W 24TH STREET, 5TH FLOOR

NEW YORK, NY, 10011

View on SEC.gov